Baxter International Inc. (BAX)
Healthcare • Medical Instruments & Supplies
StockNYSEUnited StatesUS0718131099
25.74 USD
-2.28% today Updated 13 Nov 2026 09:40
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Baxter International Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 09:40. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
11 Feb 2027
in 90 days · 08:00 · estimate 0.60
Last results
0.58 vs 0.52 estimated
29 Oct 2026 · Beat +11.9%
Beat the estimate
10 of 12
2 missed · 0 in line · 3 beats in a row
Average surprise
+9.4%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 11 Feb 2027 08:00 | 0.60 | — | — | Upcoming |
| 29 Oct 2026 07:00 | 0.52 | 0.58 | +11.9% | Beat |
| 30 Jul 2026 07:00 | 0.37 | 0.56 | +52.5% | Beat |
| 30 Apr 2026 07:00 | 0.31 | 0.36 | +15.9% | Beat |
| 12 Feb 2026 07:00 | 0.54 | 0.44 | -17.8% | Miss |
| 30 Oct 2025 07:00 | 0.60 | 0.69 | +15.4% | Beat |
| 31 Jul 2025 07:00 | 0.61 | 0.59 | -3.3% | Miss |
| 01 May 2025 07:00 | 0.48 | 0.55 | +13.8% | Beat |
| 20 Feb 2025 07:00 | 0.53 | 0.58 | +9.6% | Beat |
| 08 Nov 2024 07:00 | 0.78 | 0.80 | +3.0% | Beat |
| 06 Aug 2024 07:00 | 0.66 | 0.68 | +2.7% | Beat |
| 02 May 2024 07:00 | 0.61 | 0.65 | +7.2% | Beat |
| 08 Feb 2024 07:00 | 0.86 | 0.88 | +1.8% | Beat |
| 02 Nov 2023 07:00 | 0.68 | 0.68 | +0.3% | In line |
| 27 Jul 2023 07:00 | 0.60 | 0.55 | -8.3% | Miss |
| 27 Apr 2023 07:00 | 0.49 | 0.59 | +19.6% | Beat |
| 09 Feb 2023 07:00 | 0.94 | 0.88 | -6.1% | Miss |
| 27 Oct 2022 07:00 | 0.81 | 0.82 | +0.7% | In line |
| 28 Jul 2022 07:00 | 0.87 | 0.87 | -0.3% | In line |
| 28 Apr 2022 07:00 | 0.81 | 0.93 | +15.5% | Beat |
| 17 Feb 2022 07:00 | 1.03 | 1.04 | +1.1% | Beat |
| 28 Oct 2021 07:00 | 0.94 | 1.02 | +8.8% | Beat |
| 29 Jul 2021 07:00 | 0.75 | 0.80 | +6.9% | Beat |
| 29 Apr 2021 07:00 | 0.65 | 0.76 | +17.7% | Beat |
| 04 Feb 2021 07:00 | 0.76 | 0.80 | +4.9% | Beat |
| 29 Oct 2020 07:00 | 0.72 | 0.83 | +14.6% | Beat |
| 30 Jul 2020 07:00 | 0.71 | 0.64 | -10.1% | Miss |
| 30 Apr 2020 08:00 | 0.74 | 0.82 | +11.0% | Beat |
| 17 Mar 2020 07:00 | 0.84 | 0.79 | -6.0% | Miss |
| 25 Jul 2019 07:00 | 0.81 | 0.89 | +9.6% | Beat |
| 25 Apr 2019 07:00 | 0.68 | 0.76 | +11.6% | Beat |
| 31 Jan 2019 07:00 | 0.73 | 0.78 | +6.8% | Beat |
| 31 Oct 2018 07:00 | 0.74 | 0.80 | +8.0% | Beat |
| 26 Jul 2018 07:00 | 0.71 | 0.77 | +8.8% | Beat |
| 26 Apr 2018 07:00 | 0.62 | 0.70 | +12.6% | Beat |
| 01 Feb 2018 07:00 | 0.59 | 0.64 | +8.6% | Beat |
| 25 Oct 2017 07:00 | 0.59 | 0.64 | +8.1% | Beat |
| 26 Jul 2017 07:00 | 0.57 | 0.63 | +11.2% | Beat |
| 26 Apr 2017 07:00 | 0.51 | 0.58 | +12.7% | Beat |
| 01 Feb 2017 07:00 | 0.52 | 0.57 | +9.3% | Beat |
| 25 Oct 2016 07:00 | 0.45 | 0.56 | +25.6% | Beat |
| 26 Jul 2016 07:00 | 0.40 | 0.46 | +16.1% | Beat |
| 26 Apr 2016 07:00 | 0.29 | 0.36 | +23.4% | Beat |
| 02 Feb 2016 07:00 | 0.32 | 0.43 | +36.2% | Beat |
| 27 Oct 2015 06:00 | 0.29 | 0.41 | +39.8% | Beat |
| 29 Jul 2015 16:00 | 0.97 | 1.00 | +3.0% | Beat |
| 23 Apr 2015 07:00 | 0.88 | 1.00 | +13.9% | Beat |
| 29 Jan 2015 07:00 | 1.31 | 1.34 | +2.1% | Beat |
| 16 Oct 2014 07:00 | 1.31 | 1.35 | +3.3% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 11.2B | +5.7% | -957M | -8.5% | -1.87 | -47.2% | 323M |
| 2024 | 10.6B | +2.7% | -649M | -6.1% | -1.27 | -124.2% | 559M |
| 2023 | 10.4B | +3.0% | 2.7B | 25.6% | 5.25 | +208.7% | 1.3B |
| 2022 | 10.1B | — | -2.4B | -24.2% | -4.83 | — | 576M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 26.60 | 26.66 | 25.65 | 25.74 | -2.28% | 4,668,600 | |
| 11 Nov 2026 | 26.11 | 26.50 | 25.98 | 26.34 | -0.30% | 3,825,300 | |
| 10 Nov 2026 | 26.18 | 26.49 | 25.57 | 26.42 | +0.04% | 3,830,300 | |
| 09 Nov 2026 | 26.17 | 26.71 | 25.87 | 26.41 | +2.40% | 4,538,700 | |
| 06 Nov 2026 | 24.99 | 25.83 | 24.76 | 25.79 | +0.55% | 6,194,600 | |
| 05 Nov 2026 | 26.82 | 26.97 | 25.09 | 25.65 | -3.21% | 10,102,900 | |
| 04 Nov 2026 | 26.24 | 27.09 | 25.87 | 26.50 | +3.96% | 10,490,600 | |
| 03 Nov 2026 | 24.04 | 25.57 | 23.90 | 25.49 | +5.24% | 9,397,400 | |
| 02 Nov 2026 | 23.34 | 24.25 | 23.27 | 24.22 | +5.30% | 10,163,000 | |
| 30 Oct 2026 | 23.59 | 23.59 | 22.50 | 23.00 | -2.13% | 11,809,900 | |
| 1,249 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Barclays Maintains Underweight on Baxter International, Raises Price Target to $23 (opens in a new tab) Benzinga · 09 Nov 2026 11:23
- How Return To Profit Will Impact Baxter International Stock (BAX) (opens in a new tab) Simply Wall St. · 06 Nov 2026 18:13
- Baxter International Stock: Analyst Estimates & Ratings (opens in a new tab) Barchart · 04 Nov 2026 10:29
- Should You Buy Baxter Stock For Its Cash? (opens in a new tab) Trefis · 03 Nov 2026 19:54
- BAX Q3 deep dive: cost actions and product changes shape outlook amid market caution (opens in a new tab) StockStory · 30 Oct 2026 16:02
- Baxter International Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 30 Oct 2026 12:30
- Baxter’s shares fall as Q3 probability dips despite revenue growth (opens in a new tab) Medical Device Network · 30 Oct 2026 11:59
- What Baxter International (BAX) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 30 Oct 2026 07:14
- Baxter International (BAX) Received An FDA Warning Letter Over CGMP Violations (opens in a new tab) Simply Wall St. · 30 Oct 2026 01:17
- Baxter (BAX) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 29 Oct 2026 18:29
- Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook Raised (opens in a new tab) Zacks · 29 Oct 2026 14:48
- Baxter (NYSE:BAX) surprises with Q3 2026 sales (opens in a new tab) StockStory · 29 Oct 2026 12:46
- Compared to Estimates, Baxter (BAX) Q3 Earnings: A Look at Key Metrics (opens in a new tab) Zacks · 29 Oct 2026 12:30
- Baxter International (BAX) Q3 Earnings and Revenues Surpass Estimates (opens in a new tab) Zacks · 29 Oct 2026 11:35
- Baxter: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 29 Oct 2026 11:26
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 26.34 USD
- Market cap
- 13.3B
- Dividend yield
- 0.16%
- 5-year average yield
- 1.42%
- Payout ratio
- 155%
- Last dividend
- 0.0100 USD · 27 Nov 2026
- Next ex-dividend date
- 27 Nov 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 28 Aug 2026 | 0.0100 USD |
| 29 May 2026 | 0.0100 USD |
| 27 Feb 2026 | 0.0100 USD |
| 28 Nov 2025 | 0.0100 USD |
| 8 older dividends: create a free account to see them | |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 0.7 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 2.4 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 0.0 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 10.0 / 10 | — |
| Analysts How far the analysts' average target is from today's price. | 2.6 / 5 |
|
- Score capped at 50: the dividend was cut recently
- The dividend is above the earnings (payout 155%)
- Thin interest cover: operating profit is only 0.6× the interest
- The dividend paid in the last 12 months is lower than in the 12 before
- The last full year was a loss
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A). Warnings take 18 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 12.58× | Good | 14.16× |
| Price / book | 2.05× | Fair | 3.5× |
| Price / sales | 1.15× | Good | 3.33× |
| EV / EBITDA | 10.96× | Fair | 11.19× |
| Free cash flow yield | 9.2% | Good | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 33.4% | Fair | 54.9% |
| Operating margin | 7.6% | Weak | 5.8% |
| Net margin | -6.2% | Weak | 1.2% |
| Return on equity | -9% | Weak | 4.4% |
| Return on assets | 2.7% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 3.8% | Fair | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.36× | Fair | 0.4× |
| Net debt / EBITDA | 3.73× | Weak | 1.46× |
| Interest cover | 0.61× | Weak | 2.17× |
| Current ratio | 1.79× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 154.7% | Weak | 0% |
| Payout of free cash flow | 28.5% | Good | 28.7% |
| Payout of free cash flow (3 years) | 70.2% | Weak | — |
| Dividend growth / year | -3.7% | Weak | 6.5% |
| Years of rising dividends | 0 | Weak | 1.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow BAX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.